At a glance
ClinicalIndex Comparison RecordN/ACompleted· 90 enrolled
Drug / intervention
Remifentanil +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Remifentanil Versus Dexmedetomidine for Post-Cardiac Surgery Patients With Noninvasive Ventilation Intolerance: A Prospective, Observational,Cohort Study
In Brief
An observational study evaluating Remifentanil and Dexmedetomidine for Cardiac Surgery. Completed, enrolled 90 participants across 1 site.
Detailed Summary
The aim of this study is to compare the sedation effects between remifentanil and dexmedetomidine in post-cardiac surgical patients who developed noninvasive ventilation (NIV) intolerance.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Surgery
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJan 2018
First PostedJan 2018
Primary CompletionMar 2019
TodayJul 2026
First PostedJan 10, 2018
Enrollment StartJan 1, 2018
Primary CompletionMar 31, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.5 years ago
Interventions
Remifentanildrug
The noninvasive ventilation intolerated patients was sedated by remifentanil.
Dexmedetomidinedrug
The noninvasive ventilation intolerated patients was sedated by dexmeditomidine.